Inhaled iloprost as third add-on therapy in idiopathic pulmonary arterial hypertension

Triple combination therapy is suggested in current pulmonary arterial hypertension guidelines in case of unsatisfactory treatment with oral double combination therapy. However, there is a lack of evidence concerning some of the drug combinations currently employed. We demonstrate the clinical and he...

Full description

Saved in:
Bibliographic Details
Published inPulmonary circulation Vol. 11; no. 1; pp. 1 - 3
Main Authors Fernandes, Caio J.C.S., da Silva, Taysa A.F., Alves Jr, Jose L., Jardim, Carlos V.P., de Souza, Rogerio
Format Journal Article
LanguageEnglish
Published London, England SAGE Publications 01.01.2021
John Wiley & Sons, Inc
Wiley
Subjects
Hemodynamics
inhaled iloprost
Inhalers
Potassium
pulmonary arterial hypertension
Pulmonary hypertension
Research Letter
sequential triple combination therapy
sequential triple combination therapy
pulmonary arterial hypertension
inhaled iloprost
hemodynamics
Online AccessGet full text

Cover

More Information
Summary:Triple combination therapy is suggested in current pulmonary arterial hypertension guidelines in case of unsatisfactory treatment with oral double combination therapy. However, there is a lack of evidence concerning some of the drug combinations currently employed. We demonstrate the clinical and hemodynamical benefits of inhaled iloprost as third add-on therapy in idiopathic pulmonary arterial hypertension.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:2045-8940
2045-8932
2045-8940
DOI:10.1177/2045894020981350